Skip to main content
SpringerLink
Log in

Clinical and Pharmacological Perspectives for Treating Memory Failures

  • Chapter
Memory Improvement

Abstract

In this chapter, we provide a brief review of some of the current schemes, or models, that are available for defining the structures and processes that are involved in memory functions from both a psychological and biological perspective. This perspective is relevant for considering strategies for improving memory since the techniques that prove useful would be logically based upon what we know about the structures and processes that together operate to establish and maintain memory. We provide an overview of some of the prototypic types of memory failures associated with prevalent neuropsychiatric disorders. We discuss some pharmacological strategies that have been developed on the basis of what we know about the psychobiology of normal and impaired memory functions. In discussing these issues we first consider some of the methodological issues that must be taken into account in using drugs to alter memory functions. We review findings from studies demonstrating the highly selective memory response to drug treatments in normal controls and memory-impaired Alzheimer’s disease patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bartus, R.T., Dean, R.L., Beer, B., & Lippa, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408–417.

    Article  PubMed  Google Scholar 

  • Beller, S.A., Overall, J.E., & Swann, A.C. (1985). Efficacy of oral physostigmine in primary degenerative dementia. Psychopharmacology, 87, 147–151.

    Article  PubMed  Google Scholar 

  • Bowden, S.C. (1990). Separating cognitive impairment in neurologically asymptomatic alcoholism from Wernicke-Korsakoff syndrome: Is the neuropsychological distinction justified? Psychological Bulletin, 107, 355–366.

    Article  PubMed  Google Scholar 

  • Buell, SJ., & Coleman, P.D. (1979). Dendritic growth in the aged human brain and failure of growth in senile dementia. Science, 206, 854–856.

    Article  PubMed  Google Scholar 

  • Buell, SJ., & Coleman, P.D. (1981). Quantitative evidence for selective dendritic growth in normal human aging but not in senile dementia. Brain Research, 214, 23–41.

    Article  PubMed  Google Scholar 

  • Christie, J.E., Shering, A., Ferguson, J., & Glen, A.I.M. (1981). Physostigmine and arecoline: Effects of intravenous infusions in Alzheimer presenile dementia. British Journal of Psychiatry, 138, 46–50.

    Article  PubMed  Google Scholar 

  • Cohen, N.J., & Squire, L.R. (1980). Preserved learning and retention of pattern-analyzing skill in amnesia: Dissociation of knowing how and knowing that. Science, 210, 207–210.

    Article  PubMed  Google Scholar 

  • Cohen, R.M., Weingartner, H., Smallberg, S A., Pickar, D., & Murphy, D.L. (1982). Effort and cognition in depression. Archives of General Psychiatry, 39, 593–597.

    PubMed  Google Scholar 

  • Coyle, J.T., Price, D.L., & DeLong, M.R. (1983). Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science, 219, 1184–1190.

    Article  PubMed  Google Scholar 

  • Davies, CA., Mann, D.MA., Sumpter, P.Q., & Yates, P.O. (1987). A quantitative morphometric analysis of neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease. Journal of Neurological Science, 78, 151–164.

    Article  Google Scholar 

  • Davis, K.L., & Mohs, R.C. (1982). Enhancement of memory processes in Alzheimer’s disease with multiple-dose intravenous physostigmine. American Journal of Psychiatry, 139, 1421–1424.

    PubMed  Google Scholar 

  • Gottfries, C.G. (1985). Alzheimer’s disease and senile dementia: Biochemical characteristics and aspects of treatment. Psychopharmacology, 86, 245–252.

    Article  PubMed  Google Scholar 

  • Graf, P., Squire, L.R., & Mandler, G. (1984). The information that amnesic patients do not forget. Journal of Experimental Psychology: Learning Memory, and Cognition, 10, 164–178.

    Article  Google Scholar 

  • Graf, P., Squire, L.R., & Mandler, G. (1984). The information that amnesic patients do not forget. Journal of Experimental Psychology: Learning Memory, and Cognition, 10, 164–178.

    Article  Google Scholar 

  • Hamos, J.E., DeGennaro, L.J., & Drachman, DA. (1989). Synaptic loss in Alzheimer’s disease and other dementias. Neurology, 39, 355–361.

    PubMed  Google Scholar 

  • Hasher, L., & Zacks, R.T. (1979). Automatic and effortful processing in memory. Journal of Experimental Psychology: General, 108, 356–388.

    Article  Google Scholar 

  • Herrmann, D.J., & Searleman, A. (1990). The new multimodal approach to memory improvement. In G.H. Bower (Ed.), Advances in learning and motivation (Vol. 26, pp. 175–205 ). New York: Academic Press.

    Google Scholar 

  • Hirst, W., & Volpe, B.T. (1984). Automatic and effortful encoding in amnesia. In M.S. Gazzaniga (Ed.), Handbook of cognitive neuroscience (pp. 369–386 ). New York: Plenum.

    Google Scholar 

  • Jacoby, L.L., & Witherspoon, D. (1982). Remembering without awareness. Canadian Journal of Psychology, 36, 300–324.

    Article  Google Scholar 

  • Janowsky, J.S., Shimamura, A.P., Kritchevsky, M., & Squire, L.R. (1989). Cognitive impairment following frontal lobe damage and its relevance to human amnesia. Behavioral Neuroscience, 103, 548–560.

    Article  PubMed  Google Scholar 

  • Kahneman, D. (1973). Attention and effort. Englewood Cliffs, NJ: Prentice-Hall.

    Google Scholar 

  • Kaye, W., Sitaram, N., Weingartner, H., Ebert, M., Gillin, J.C., & Smallberg, SA. (1982). Modest facilitation of memory in dementia with combined lecithin and anticholinesterase treatment. Biological Psychiatry, 17, 275–280.

    PubMed  Google Scholar 

  • Lister, R.G., & Weingartner, H.J. (1987). Neuropharmacology strategies for understanding psychobiological determinants of cognition. Human Neurobiology, 6, 119–127.

    PubMed  Google Scholar 

  • McGeer, P.L., McGeer, E.G., Suzuki, J., Dolman, C.E., & Nagai, T. (1984). Aging, Alzheimer’s disease, and the cholinergic system of the basal forebrain. Neurology, 34, 741–745.

    PubMed  Google Scholar 

  • Molchan, S.E., Mellow, A.M., Lawlor, B A., Weingartner, H.J., Cohen, R.M., Cohen, M.R., & Sunderland, T. (1990). TRH attenuates scopolamine- induced memory impairment in humans. Psychopharmacology, 100, 84–89.

    Article  PubMed  Google Scholar 

  • Perruchet, P., & Baveux, P. (1989). Correlational analyses of explicit and implicit memory performance. Memory & Cognition, 17, 77–86.

    Article  Google Scholar 

  • Roy-Byrne, P., Weingartner, H., Bierer, L., Thompson, K., & Post, R. (1986). Effortful and automatic cognitive processes in depression. Archives of General Psychiatry, 43, 265–267.

    PubMed  Google Scholar 

  • Schacter, D.L. (1987). Implicit memory: History and current status. Journal of Experimental Psychology: Learning Memory, and Cognition, 13, 501–518.

    Article  Google Scholar 

  • Schneider, W., & Shiffrin, R.M. (1977). Controlled and automatic human information processing: I. Direction, search, and attention. Psychological Review, 84, 1–66.

    Article  Google Scholar 

  • Shiffrin, R.M., & Schneider, W. (1977). Controlled and automatic human information processing: II. Perceptual learning, automatic attending, and a general theory. Psychological Review, 84, 127–190.

    Article  Google Scholar 

  • Sitaram, N., Weingartner, H., & Gillin, J.C. (1978). Human serial learning: Enhancement with arecoline and choline and impairment with scopolamine. Science, 201, 274–276.

    Article  PubMed  Google Scholar 

  • Strauss, M.E., Weingartner, H., & Thompson, K. (1985). Remembering words and how often they occurred in memory-impaired patients. Memory & Cognition, 13, 507–510.

    Article  Google Scholar 

  • Tariot, P.N., Cohen, R.M., Welkowitz, J A., Sunderland, T., Newhouse, PA., Murphy, D.L., & Weingartner, H. (1988). Multiple dose arecoline infusions in Alzheimer’s disease. Archives of General Psychiatry, 45, 901–905.

    PubMed  Google Scholar 

  • Tariot, P.N., & Weingartner, H. (1986). A psychobiologic analysis of cognitive failures. Archives of General Psychiatry, 43, 1183–1188.

    PubMed  Google Scholar 

  • Thompson, R.F. (1986). The neurobiology of learning and memory. Science, 233, 941–947.

    Article  PubMed  Google Scholar 

  • Tulving, E. (1985). How many memory systems are there? American Psychologist, 40, 385–398.

    Article  Google Scholar 

  • Weingartner, H., Cohen, R.M., Martello, J.D.I., & Gerdt, C. (1981). Cognitive processes in depression. Archives of General Psychiatry, 38, 42–47.

    PubMed  Google Scholar 

  • Weingartner, H., Grafman, J., Boutelle, W., Kaye, W., & Martin, P. (1983). Forms of memory failure. Science, 221, 380–382.

    Article  PubMed  Google Scholar 

  • Weingartner, H., Sitaram, N., & Gillin, J.C. (1979). The role of the cholinergic nervous system in memory consolidation. Bulletin of the Psychonomic Society, 13, 9–11.

    Google Scholar 

  • Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., & DeLong, M.R. (1982). Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 1237–1239.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Herbert Weingartner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National Center for Health Statistics, 20782, Hyattsville, MD, USA

    Douglas J. Herrmann

  2. NIMH, 20892, Bethesda, MD, USA

    Herbert Weingartner

  3. Department of Psychology, St. Lawrence University, 13617, Canton, NY, USA

    Alan Searleman

  4. Department of Aging and Mental Health, University of South Florida, 13301 Bruce B. Downs Blvd., 33612-3899, Tampa, FL, USA

    Cathy McEvoy

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Weingartner, H., Herrmann, D. (1992). Clinical and Pharmacological Perspectives for Treating Memory Failures. In: Herrmann, D.J., Weingartner, H., Searleman, A., McEvoy, C. (eds) Memory Improvement. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2760-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2760-1_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7656-2

  • Online ISBN: 978-1-4612-2760-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation